GREGORY J. FLESHER Insider Trading $ELDN Eledon Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY J. FLESHER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY J. FLESHER. GREGORY J. FLESHER is Chief Executive Officer in Novus Therapeutics, Inc. ($TKAI).
GREGORY J. FLESHER in Eledon Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY J. FLESHER: Chief Executive Officer
Holdings: 159,855 shares
Current Value: $145,468
Latest Transaction: Mar 20 2020
$ELDN Market Capitalization: $20.25M
$ELDN Previous Close: $0.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GREGORY J. FLESHER in Eledon Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 2020 | NVUS | Novus Therapeutics ... | FLESHER GREGORY J. | Chief Executive Off ... | Option Exercise | A | 0.26 | 200,000 | 52,000 | 200,000 | |
| Sep 30 2019 | NVUS | Novus Therapeutics ... | FLESHER GREGORY J. | Chief Executive Off ... | Option Exercise | A | 0.67 | 100,000 | 67,000 | 100,000 | |
| Sep 30 2019 | NVUS | Novus Therapeutics ... | FLESHER GREGORY J. | Chief Executive Off ... | Option Exercise | A | 0.67 | 100,000 | 67,000 | 100,000 | |
| May 22 2019 | NVUS | Novus Therapeutics ... | FLESHER GREGORY J. | Chief Executive Off ... | Sell | S | 1.91 | 2,937 | 5,614 | 156,918 | 159.9 K to 156.9 K (-1.84 %) |
| May 22 2019 | NVUS | Novus Therapeutics ... | FLESHER GREGORY J. | Chief Executive Off ... | Sell | S | 1.96 | 11,701 | 22,953 | 159,855 | 171.6 K to 159.9 K (-6.82 %) |
| Mar 18 2019 | NVUS | Novus Therapeutics ... | FLESHER GREGORY J. | Chief Executive Off ... | Option Exercise | A | 3.72 | 90,000 | 334,800 | 90,000 | |
| Mar 18 2019 | NVUS | Novus Therapeutics ... | FLESHER GREGORY J. | Chief Executive Off ... | Grant | A | 0.00 | 25,000 | 0 | 171,556 | 146.6 K to 171.6 K (+17.06 %) |
| Mar 15 2018 | TKAI | Novus Therapeutics ... | FLESHER GREGORY J. | Chief Executive Off ... | Option Exercise | A | 4.83 | 56,500 | 272,895 | 56,500 | |
| Mar 15 2018 | TKAI | Novus Therapeutics ... | FLESHER GREGORY J. | Chief Executive Off ... | Grant | A | 0.00 | 30,700 | 0 | 146,556 | 115.9 K to 146.6 K (+26.50 %) |
| May 26 2017 | TKAI | Novus Therapeutics ... | FLESHER GREGORY J. | Chief Executive Off ... | Option Exercise | A | 5.50 | 250,000 | 1,375,000 | 250,000 | |
| May 11 2017 | TKAI | Novus Therapeutics ... | FLESHER GREGORY J. | Chief Executive Off ... | Buy | P | 9.99 | 58,959 | 589,000 | 115,856 | 56.9 K to 115.9 K (+103.62 %) |
Page: 1